Vertex Pharmaceuticals
VRTX
#206
Rank
S$140.84 B
Marketcap
S$554.94
Share price
0.23%
Change (1 day)
-3.15%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2026 (TTM): S$6.49 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are S$12.21 Billion. In 2025 the company made an earning of S$6.32 Billion, an increase over its 2024 earnings that were of S$0.35 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$6.49 B2.59%
2025 S$6.32 B1675.06%
2024 S$0.35 B-93.69%
2023 S$5.64 B3.19%
2022 S$5.47 B53.56%
2021 S$3.56 B-12.06%
2020 S$4.05 B118.45%
2019 S$1.85 B120.64%
2018 S$0.84 B1473.64%
2017 S$53.46 M197.6%
2016 S$17.96 M-102.97%
2015 -S$0.61 Billion-28.46%
2014 -S$0.85 Billion-51.5%
2013 -S$1.75 Billion-30584.68%
2012 S$5.71 M-95.47%
2011 S$0.12 B
2009 -S$0.76 Billion
2007 -S$0.53 Billion83.1%
2006 -S$0.29 Billion59.02%
2005 -S$0.19 Billion3.28%
2004 -S$0.18 Billion-38.16%
2003 -S$0.29 Billion
2000 -S$48.59 Million-20.38%
1999 -S$61.02 Million31.62%
1998 -S$46.36 Million91.05%
1997 -S$24.27 Million-36.24%
1996 -S$38.06 Million12.45%
1995 -S$33.85 Million27.4%
1994 -S$26.57 Million-1833.33%
1993 S$1.53 M-112.12%
1992 -S$12.65 Million175%
1991 -S$4.6 Million-12.2%
1990 -S$5.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.17 B 413.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$8.42 B 30.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$12.51 B 93.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$16.79 B 159.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.25 B 89.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-S$96.9 Million-101.50%๐Ÿ‡บ๐Ÿ‡ธ USA